openPR Logo
Press release

Atex announces new CEO of Asia

01-23-2012 02:45 PM CET | IT, New Media & Software

Press release from: Atex

Jerome Laredo

Jerome Laredo

Atex, a leading software company providing solutions for media-rich industries, has appointed Jerome Laredo as Chief Executive Officer of Asia, with immediate effect.

Based at Atex Asia’s headquarters in Singapore, Jerome will support and guide the region’s accelerated growth and development, to a multi-industry digital content and advertising innovator.

Jerome brings more than 15 years of software sales experience to Atex. He joined the company in 2008 and until recently, held the position of VP of Sales, EMEA, where he spearheaded the expansion into a number of emerging markets with a strong focus on digital products.

Jerome has also held roles in EMEA for Nstein Technologies, Teleglobe and Ixiasoft where he was instrumental in building successful sales teams, developing efficient resellers' channels and driving new business. He holds an MSc in International Business from HEC Montréal.

Jim Rose, Atex Group CEO, said, “Jerome has an exceptional record of leading businesses through expansion, and we are delighted to have someone of his caliber on board, to propel Atex Asia through its next stage of growth. His leadership and experience will be invaluable to our team.”

Jerome comments, “I am privileged to be embarking on such an exciting role at Atex and look forward to being part of the future success of Atex Asia.”

Atex, headquartered in the UK with offices worldwide, is a leading software company providing solutions for media-rich industries. Atex develops smart digital solutions that make a measurable difference and enable its 1000+ customers to streamline operations and optimise their digital strategy.

Please visit for further information.

Atex, Advantage, 87 Castle Street, Reading, Berkshire RG1 7SN, UK

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Atex announces new CEO of Asia here

News-ID: 208064 • Views:

More Releases from Atex

Leading Kinetic Tape Manufacturer in Korea | ATEX
ATEX CO., LTD. is a leading kinetic tape manufacturer in Korea. It specializes in the creation of high-quality tapes that are both long-lasting and efficient. ATEX tapes are made of high-quality, breathable fabrics that are both comfortable to wear and water-resistant. They are also free of latex, making them ideal for anyone with sensitive skin. ATEX Kinetic Tapes: Championing Pain Relief and Performance: ATEX's SportsTex brand is synonymous with top-notch kinesiology therapeutic tapes.
Spiral Tape Manufacturer in Korea | ATEX
Spiral Tape Manufacturer in Korea | ATEX
ATEX CO., LTD. spiral tape is a type of kinesiology tape specifically designed for pain relief based on the balancing therapy of Oriental Medicine. It works by attaching grid-like cross tapes to acupoints to control the tension and relaxation of the whole body. Atex spiral tape comes in different sizes and colors and is made from high-quality, breathable materials that are comfortable to wear and water-resistant. Benefits of using Atex spiral tape:
Leading Pain Relief Tape Manufacturer in Korea | ATEX
ATEX CO., LTD. is a leading pain relief tape manufacturer in Korea.They are made with premium materials, such as 97% cotton fabric and hypoallergenic adhesive, making them comfortable to wear and gentle on the skin. The tapes are also water-resistant and can last for several days when applied properly. Atex tapes are used by a variety of people, including athletes, physical therapists, and occupational therapists. They can be used to treat
Original and Largest Kinesiology Therapeutic Tape Manufacturer in Korea | ATEX
ATEX CO., LTD. is the original and largest Kinesiology Therapeutic Tape manufacturer Korea, with over two decades of manufacturing experience. They export premium-quality private-label kinesiology tape to Europe, Asia, North America, and Latin America. Their house brand is called SportsTex. ATEXKinesiology Tape Kinesiology taping has gained significant traction in recent years as a tool for pain management and preventive practices. Its potential to influence the neurological and circulatory systems, offering both decompression

All 5 Releases

More Releases for Jerome

Differentiated Thyroid Cancer Treatment Market Exhibits a Stunning Growth by 202 …
This Differentiated Thyroid Cancer Treatment market report uses a technique that includes a demand-side strategic analysis and triangulates it with supply-side analysis. This report not only provides estimates and projections, but also a clear assessment of these statistics in terms of market changing aspects. For business owners, authorities, and investors, these insights combine a data-driven research approach with qualitative sessions. The info and data will also support the clients in
Differentiated Thyroid Cancer Therapeutics Market Boosts Massive Revenue by 2028 …
Differentiated thyroid cancer (DTC) includes papillary thyroid cancer (PTC), which accounts for 80% of all thyroid cancers, follicular thyroid cancer (FTC), which accounts for 10% to 20% of all thyroid cancers, and a rare type, Hürthle cell cancer. Medullary thyroid cancer has a lower cure rate than other thyroid cancers. When the cancer is confined to the thyroid, the 10-year survival rate is around 90%. When it has spread to the
JEROME, Arizona: ​The Haunted Group hospitality group, known for putting Cottonwood and Jerome “on the map” as Northern Arizona tourism destinations, breathes new life into Jerome with their latest concept: The Clinkscale Hotel, Bar + Grill. The versatile establishment spans the historic Clinkscale building, originally built in 1899, with the restaurant and bar on the ground floor, and six exquisite questrooms on the upper floors. Exposed brick, hardwood floors, brown leather
Levoxyl Market is Booming Worldwide By Top Emerging Players: Abbvie, Mylan, Merc …
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Levoxyl Market Research Report 2020". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Levoxyl market. Players can use the accurate market facts and figures and statistical
Differentiated Thyroid Cancer Therapeutics Market Size, Analysis, Growth Factors …
This detailed market study covers differentiated thyroid cancer therapeutics market growth potentials which can assist the stake holders to understand key trends and prospects in differentiated thyroid cancer therapeutics market identifying the growth opportunities and competitive scenarios. The report also focuses on data from different primary and secondary sources, and is analyzed using various tools. It helps to gain insights into the market's growth potential, which can help investors identify
Thyroid Cancer Treatment Market Key Information By Top Key Player Abbott, Baxter …
The worldwide Thyroid Cancer Treatment Market is expected to grow at a CAGR of roughly 27.7% over the next five years, will reach 1480 million US$ in 2023, from 340 million US$ in 2017, according to a new research report. Thyroid cancer is cancer that develops from the tissues of the thyroid gland. It is a disease in which cells grow abnormally and have the potential to spread to other parts